NYSE · AORTHealthcareSurgical Instruments

Artivion financials

$22.86−0.39%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
FY23
Dec 31
FY22
Dec 31
Revenue$441.3M$388.5M$354.0M$313.8M
Gross profit$284.2M$248.8M$229.2M$202.5M
Gross margin64.4%64.0%64.7%64.5%
Operating income$26.7M$38.9M-$8.5M$6.2M
Net income$9.8M-$13.4M-$30.7M-$19.2M
Net margin2.2%−3.4%−8.7%−6.1%
Diluted EPS$0.21$-0.32$-0.75$-0.48
EBITDA$49.2M$63.1M$14.6M$28.6M
Operating cash flow$39.9M$22.2M$18.8M-$5.2M
Free cash flow$839.0K$11.0M$9.1M-$15.9M
Diluted shares47.2M41.7M40.7M40.0M

Balance sheet

Period endDec 31Dec 31Dec 31Dec 31
Cash & equivalents$64.9M$53.5M$58.9M$39.4M
Short-term investments$0.00$0.00$0.00$0.00
Total debt$223.4M$326.0M$313.3M$312.3M
Total assets$884.8M$789.1M$792.4M$762.8M
Total liabilities$436.6M$512.9M$510.6M$478.5M
Shareholders' equity$448.2M$276.2M$281.8M$284.3M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology